4 Evaluation of the efficacy and safety of tirzepatide in the treatment of type 2 diabetes and cardiovascular risk management 4.1 SURPASS-1: efficacy of tirzepatide on HbA1c and weight change The SURPASS-1 trial included 478 patients and compared the efficacy of tirzepatide at doses of 5 mg, 10 mg, and 15 mg
Patients often become discouraged when the scale stops moving, but a plateau is a normal part of successful medical weight loss
In particular, avoid spicy foods, chocolate, most processed/high-fat foods (chips, etc.), and limit your dairy intake
This meeting not only allows us to meet each patient but also to recommend the best treatment for their needs
Individual results vary by dose, adherence, and personal response, and not everyone needs to reach the maximum dose to see meaningful change
Lancet Diabetes Endocrinol 2:417426 DAgati VD, Chagnac A, de Vries AP et al (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis